Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban switching study with apixaban lead-in in healthy volunteers
NL-OMON36871Active, not recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of edoxaban and apixaban in thrombosis (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Prothrombin time. Started Sep 2012; status: active, not recruiting.
02
Drugs
edoxabanapixaban
03
Conditions
thrombosis
Beyond the preview
Go deeper on NL-OMON36871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36871.